LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.31623
76.89 27.76 3312 7025 0.4714 0.8202
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
76.89 27.76 3915 7025 0.5573 0.8588
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
76.89 27.76 4089 7025 0.5821 0.8689
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
76.89 27.76 185 7025 0.0263 0.2682
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
76.89 27.76 4606 7025 0.6556 0.8970
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
78.60 27.76 3378 7045 0.4794 0.8242
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
78.60 27.76 3430 7045 0.4868 0.8276
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
78.60 27.76 4032 7045 0.5723 0.8650
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
78.60 27.76 4266 7045 0.6055 0.8782
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
78.60 27.76 57 7045 0.0081 0.0943
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
78.60 27.76 4783 7045 0.6789 0.9053
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
80.31 27.76 3455 6976 0.4953 0.8313
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
80.31 27.76 3511 6976 0.5033 0.8350
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
80.31 27.76 3948 6976 0.5659 0.8622
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
80.31 27.76 4334 6976 0.6213 0.8841
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
80.31 27.76 34 6976 0.0049 0.0258
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
80.31 27.76 4879 6976 0.6994 0.9123
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
82.01 27.76 3546 7000 0.5066 0.8366
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
82.01 27.76 3636 7000 0.5194 0.8424
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
82.01 27.76 3663 7000 0.5233 0.8441
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
82.01 27.76 4439 7000 0.6341 0.8890
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
82.01 27.76 10 7000 0.0014 -0.1201
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
82.01 27.76 5061 7000 0.7230 0.9203
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
83.72 27.76 3664 7055 0.5193 0.8425
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
83.72 27.76 3722 7055 0.5275 0.8461
MN20160318_Q01
G09